What's in Beijing Bozhiyin T&S Co., Ltd.'s pipeline?

Beijing Bozhiyin T&S Co., Ltd. has 3 drugs in our index: 3 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Beijing Bozhiyin T&S Co., Ltd.'s portfolio?

Top competitors by shared drug class: Beth Israel Deaconess Medical Center, Britannia Pharmaceuticals Ltd., China Academy of Chinese Medical Sciences, Desitin Arzneimittel GmbH, Dongzhimen Hospital, Beijing.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/beijing-bozhiyin-t-s-co-ltd.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Beijing Bozhiyin T&S Co., Ltd. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Beijing Bozhiyin T&S Co., Ltd. pipeline: 3 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

3 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
DAM	DAM	marketed	Dopamine agonist	Dopamine receptor	Neurology
High dose WenXin keli	High dose WenXin keli	marketed	Traditional Chinese medicine / herbal formulation		Cardiovascular
Low dose WenXin keli	Low dose WenXin keli	marketed	Traditional Chinese medicine herbal formulation		Cardiovascular

Therapeutic area mix

Cardiovascular · 2
Neurology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Beth Israel Deaconess Medical Center · 1 shared drug class
Britannia Pharmaceuticals Ltd. · 1 shared drug class
China Academy of Chinese Medical Sciences · 1 shared drug class
Desitin Arzneimittel GmbH · 1 shared drug class
Dongzhimen Hospital, Beijing · 1 shared drug class
GlaxoSmithKline · 1 shared drug class
Intec Pharma Ltd. · 1 shared drug class
Axxonis Pharma AG · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Beijing Bozhiyin T&S Co., Ltd.:

Cite this brief

Drug Landscape (2026). Beijing Bozhiyin T&S Co., Ltd. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/beijing-bozhiyin-t-s-co-ltd. Accessed 2026-05-17.